ArticleClinical rheumatology2025

Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.

Bahar Mikaeili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.